The delegation, featuring firms such as Vispek, GEE•D, InnAIO, SkylandX, GastroEase Biotech, and i2Cool, spent the four-day event pitching to international investors and industry leaders. For these companies, the exhibition served as a testing ground for global market viability. Eva Yu, partner at InnAIO, reported immediate traction, noting that the firm sold out its demonstration units for real-time translation and voice cloning technology while securing new overseas partnerships.

Ehub’s presence in Paris aligns with Shenzhen’s broader strategy to elevate its international profile ahead of hosting the 2026 APEC meeting. By bridging the gap between local research and global capital, the hub acts as a conduit for the 415 enterprises currently operating within its Shenzhen-Hong Kong campus. This infrastructure is bolstered by deep ties to top-tier academic institutions; five of Hong Kong’s universities ranked in the QS World Top 100 maintain dedicated research bases at the site. As the hub moves forward, its mission remains focused on scaling domestic startups into international players by leveraging its network of over RMB 9.5 billion in collective funding and cross-border commercialization support.